
BioNTech SE (BNTX) Earnings Dates & Reports
BioNTech SE (BNTX) Most Recent Earnings
Report Date
Period EndingQ4 2025
Est. EPS-$0.47
Actual EPS-$0.38
EarningsBeat
BioNTech SE (BNTX) Earnings
View the latest BioNTech SE (BNTX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in BioNTech SE (BNTX)
Order type
Buy in
Order amount
Est. shares
0 shares
BioNTech SE (BNTX) Earnings per Share (EPS) History
Signup for full accessBrowse free
BioNTech SE (BNTX) Latest Earnings
The value each BNTX share was expected to gain vs. the value each share gained.
BioNTech SE (BNTX) reported its most recent earnings on for Q4 2025, posting earnings per share (EPS) of -$0.38. This exceeded analysts' expectations of -$0.47 by 19.15%, marking a Beat.
For comparison, BioNTech SE reported EPS of $1.15 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.93.
BioNTech SE (BNTX) Earnings History
BioNTech SE (BNTX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the BioNTech SE’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
BioNTech SE (BNTX) Earnings FAQs
BioNTech SE (BNTX) last reported earnings on Mar 10, 2026 for Q4 2025, posting an EPS of -$0.38, which Beat the estimate of -$0.47 by 19.15%.
For Q4 2025, BioNTech SE (BNTX) reported an EPS of -$0.38, exceeding analysts' estimate of -$0.47 by 19.15%.
For Q4 2025, BioNTech SE (BNTX) Beat expectations with an actual EPS of -$0.38 vs. an estimated EPS of -$0.47.
Following the last earnings report on Mar 10, 2026, BioNTech SE (BNTX)'s stock price moved — from — to —.
The next BioNTech SE (BNTX) earnings call is scheduled for May. 4, 2026, where executives will discuss financial results and outlook.